SB3896Introduced in the Senate
WHOLESALE DRUG DISTRIBUTORS
Introduced by Suzanne Glowiak Hilton, District 23
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
Amends the Wholesale Drug Distribution Licensing Act. Defines "virtual wholesale distributor". Provides that every virtual wholesale distributor that engages in virtual drug distribution of prescription drugs shall be licensed by the Department of Financial and Professional Regulation. Provides that a virtual wholesale distributor shall only contract with entities licensed under the Act to take physical possession of prescription drugs if the prescription drugs are being shipped into the State. Sets forth requirements for applicants for a virtual wholesale distributor license. Provides that a virtual wholesale distributor shall ensure that any licensed entity providing distribution services to the virtual wholesale distributor complies with certain requirements. Provides that a virtual wholesale distributor shall not operate out of a location that is a residence or personal dwelling. Makes conforming changes in provisions concerning definitions; unlicensed practice; the expiration of a license; rules and regulations; inspection powers of a pharmacy investigator; restrictions on transactions; wholesaler licensing complaints; violations of the Act; temporary suspension of a license; home rule preemption; and drugs in storage. Makes other changes. Effective immediately.
Where it stands
Public Act . . . . . . . . . 104-0745
July 31, 2026
How did lawmakers vote?
House votes
2 recorded votes · each counted separately
Senate votes
2 recorded votes · each counted separately
HouseStage: House Third Reading · May 22, 2026
99
Yes
0
No
1
Absent or Not Voting
100 representatives recorded in this House vote. Colors show vote categories only, not whether a vote was good or bad.
See how each representative voted
| Representative | District | Vote |
|---|---|---|
| Elizabeth Hernandez | 2 | Yes |
| Eva Dina Delgado | 3 | Yes |
| Lilian Jimenez | 4 | Yes |
| Sonya Harper | 6 | Yes |
| Emanuel Welch | 7 | Yes |
| LaShawn Ford | 8 | Yes |
| Yolanda Morris | 9 | Yes |
| Ann Williams | 11 | Yes |
| Kelly Cassidy | 14 | Yes |
| Michael Kelly | 15 | Yes |
Bill history
Filed with Secretary by Sen. Suzy Glowiak Hilton
First Reading
Referred to Assignments
Assigned to Licensed Activities
Do Pass Licensed Activities; 008-000-000
Placed on Calendar Order of 2nd Reading March 10, 2026
Second Reading
Placed on Calendar Order of 3rd Reading March 24, 2026
Third Reading - Passed; 047-000-000
Added as Co-Sponsor Sen. Mattie Hunter
Arrived in House
Chief House Sponsor Rep. Theresa Mah
First Reading
Referred to Rules Committee
Added as Chief Co-Sponsor Sen. Elgie R. Sims, Jr.
Assigned to Prescription Drug Affordability & Accessibility Committee
Committee Deadline Extended-Rule 9(b) May 15, 2026
Do Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000
Placed on Calendar 2nd Reading - Short Debate
Second Reading - Short Debate
Placed on Calendar Order of 3rd Reading - Short Debate
Third Reading - Short Debate - Passed 099-000-000
Passed Both Houses
Added Alternate Co-Sponsor Rep. Camille Y. Lilly
Sent to the Governor
Added as Co-Sponsor Sen. Mary Edly-Allen
Governor Approved
Effective Date July 31, 2026
Public Act . . . . . . . . . 104-0745
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.